SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $3,355,000 | -43.2% | 29,186 | -22.8% | 0.01% | -56.2% |
Q3 2014 | $5,904,000 | +11.4% | 37,786 | -12.1% | 0.02% | +14.3% |
Q2 2014 | $5,302,000 | +50.6% | 42,986 | +26.5% | 0.01% | +27.3% |
Q1 2014 | $3,521,000 | +134.6% | 33,986 | +103.7% | 0.01% | +175.0% |
Q4 2013 | $1,501,000 | +42.7% | 16,686 | -35.8% | 0.00% | -20.0% |
Q4 2012 | $1,052,000 | – | 26,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zurcher Kantonalbank (Zurich Cantonalbank) | 173,845 | $7,037,000 | 0.28% |
AMUNDI ASSET MANAGEMENT US, INC. | 537,900 | $21,774,000 | 0.09% |
NOMURA HOLDINGS INC | 127,903 | $5,175,000 | 0.06% |
GOLDMAN SACHS GROUP INC | 386,458 | $15,641,000 | 0.01% |
AQR Capital Management | 26,000 | $1,052,000 | 0.01% |
GOLDMAN SACHS GROUP INC | 100,000 | $4,047,000 | 0.00% |
RATIONAL ADVISORS LLC | 288 | $12,000 | 0.00% |
HSBC HOLDINGS PLC | 5,448 | $220,000 | 0.00% |